Head-to-head · WeighScore
Alloy vs eMI Aesthetics
By GLP-1 ScorecardUpdated
Score comparison
Alloy has the higher recorded score — 72.2/100 to 70.3/100, but only just.
Alloy grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Alloy combines a $99 monthly Weight Care fee with separately priced branded and compounded medication. Confirm the dose price, state availability and both cancellation deadlines. eMI Aesthetics is close behind and may still be the better fit — see the factor split below.
Before you choose
Before comparing the headline prices, the Alloy review and the eMI Aesthetics review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Alloy vs FormidableMD and AlyveRx vs eMI Aesthetics compare each of them with another graded program, and the list of alternatives to Alloy ranks the programs closest to Alloy on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the GoodLife Health review covers one graded close to these two, at 69.8/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Alloy | eMI Aesthetics |
|---|---|---|
| WeighScore | 72.2/100 | 70.3/100 |
| Grade | C | C |
| Site position | #91 | #118 |
| Semaglutide | From $169/mo (compounded, including care) | $179/mo (all doses, compounded) |
| Tirzepatide | From $199/mo (compounded, including care) | Not disclosed |
| Coverage | Compounded options exclude AL, AR, CA, NV, LA, MS and DC | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Strengths
- Publishes the recurring care fee separately from medication
- Lists branded and compounded options and includes ongoing physician messaging
What to consider
- Medication prices are advertised starts, with care billed separately
- Care renewal and shipment cancellation have different deadlines
- Compounded options are unavailable in seven listed jurisdictions
Strengths
- Available to eligible patients in all 50 states
- Offers both semaglutide and tirzepatide, plus an oral semaglutide option
- Intake and provider visits run through OpenLoop Health, an established telehealth network
What to consider
- Full per-drug pricing is not shown before intake; only an 'as low as 179/month' starting rate is published
- No fill pharmacy or named medical director is publicly listed
- Support appears limited to email, with no phone number or hours published
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.